HCW Biologics seeks FDA pre-IND meeting for HCW11-018b T-cell engager programPUBT·Jul 23 at 07:04 AMHCWB-13.19%
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·Jul 20 at 07:05 AMBRNS+0.32%VBIO+3.85%
HCW Biologics settles $2.8M of disputed payables, removes $1.1M lienTradingView·Jul 1 at 07:33 AMHCWB-13.19%
HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter | HCWB Stock NewsStockTitan·Jun 29 at 11:25 PMHCWB-13.19%
HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026 | HCWB Stock NewsStockTitan·Jun 25 at 11:55 PMHCWB-13.19%
Microcap HCW Biologics' Therapy Shows Early Promise Against Autoimmune Hair Lossbenzinga_article·Jun 16 at 09:20 AMHCWB-13.19%
HCW Biologics reports positive Phase 1 readout for HCW9302; 3/3 responders at 3 µg/kg, no serious IL-2 toxicitiesTradingView·Jun 16 at 06:23 AMHCWB-13.19%
HCWB: Shareholders approved all proposals as clinical and financial milestones were highlightedQuartr·Jun 15 at 10:18 AMHCWB-13.19%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Jun 9 at 12:06 PMALHC-2.85%NUVL0.00%
